GGrantIndex
Sort

40,608 grants matching prostate cancer

Interactive Image Guided Closed Loop Thermal Therapy

$689,442
Roger J McNichols · Biotex, Inc. · R44 · FY2006 · CA

DEVELOPMENT OF A COMBINATION THERAPY FOR PROSTATE CANCER BY TARGETING STAT3 AND HIF-1ALPHA

$689,393
Baylor College Of Medicine · · FY2010 · Department of Defense

Epigenetic aging as a driver of racial disparities in early onset prostate cancer

$689,210
Anna Woloszynska-Read · Roswell Park Cancer Institute Corp · R01 · FY2025 · CA

(PQ11) Immune modulatory effects of white button mushroom in prostate cancer - A translational research

$689,092
Shiuan Chen · Beckman Research Institute/City Of Hope · R01 · FY2019 · CA

GLOBAL EPIGENETIC CHANGES MAY UNDERLIE ETHNIC DIFFERENCES AND SUSCEPTIBILITY TO PROSTATE CANCER

$689,016
Howard University · · FY2011 · Department of Defense

PRECISION TARGETING OF CASTRATION-RESISTANT PROSTATE CANCER WITH A NOVEL FERROUS IRON-DEPENDENT THERAPEUTIC DELIVERY AND TUMOR IMAGING STRATEGY

$688,953
Regents Of The University Of California, San Francisco, The · · FY2018 · Department of the Army

Clinical trials employing cancer vaccine combination therapies

$688,838
James L. Gulley · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA

Cancer Therapy Clinical Trials Using Novel Recombinant Vaccines

$688,838
James L. Gulley · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA

Phase II Clinical Trial of Polyphenon E in Prostate Cancer

$688,824
Nagi B Kumar · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2011 · CA

Genetic Predictors of Prostate Cancer Survival

$688,765
Robert J. Klein · Icahn School Of Medicine At Mount Sinai · R01 · FY2023 · CA

Ultrasound imaging and local drug delivery in tumors

$688,753
Katherine W Ferrara · University Of California At Davis · R01 · FY2012 · CA

Role of HSP90 Family Chaperone Proteins in Cellular Signal Transduction

$688,740
Leonard Neckers · Division Of Clinical Sciences - Nci · ZIA · FY2011 · CA

Enhancing olfactory receptor expression for biochemical studies of odorant-receptor interactions

$688,557
Hiroaki Matsunami · Duke University · R01 · FY2022 · DC

Optimizing Lung Cancer Screening in Cancer Survivors

$688,469
Juan P Wisnivesky · Icahn School Of Medicine At Mount Sinai · R01 · FY2025 · CA

MMC, VICC & TSU: Partners in Eliminating Cancer Disparities (3 of 3)

$688,440
Baqar A Husaini · Tennessee State University · U54 · FY2013 · CA

Orally active CBP/p300 degraders

$688,392
Shaomeng Wang · University Of Michigan At Ann Arbor · R01 · FY2024 · CA

Urban Latino African American Cancer Disparities Project

$688,329
Daniel Freeman Memorial Hospital · U56 · FY2004 · CA

Colorectal Tumor Risk Prediction in the PLCO Trial

$688,181
Ulrike Peters · Fred Hutchinson Cancer Research Center · U01 · FY2015 · CA

A Platform for Cancer Biomarker Validation: Image Fusion Using NIR Fluorescence

$688,070
John V Frangioni · Beth Israel Deaconess Medical Center · R01 · FY2012 · CA

A Statistical Physics Framework for Understanding the Role of Repeat RNA in Tumor Immunity

$688,005
Benjamin Greenbaum · Sloan-Kettering Inst Can Research · U01 · FY2020 · CA

3D Microscopy with Ultraviolet Surface Excitation (3D-MUSE)

$687,794
David L Wilson · Case Western Reserve University · R01 · FY2019 · EB

ISOLATION AND CHARACTERIZATION OF PROSTATE CANCER STEM CELLS

$687,654
University Of California, Los Angeles · · FY2008 · Department of the Army

Statistical Informatics for Cancer Research

$687,641
Xihong Lin · Harvard School Of Public Health · P01 · FY2014 · CA

San Juan Minority - Based Community Clinical Oncology Program

$687,330
Luis Baez · Municipio De San Juan · U10 · FY2009 · CA

Molecular Phenotypes for Lung Diseases

$687,318
David Brian Corry · Baylor College Of Medicine · R01 · FY2011 · HL